Cordis Corp., a Johnson & Johnson company, acquired device developer Ensure Medical, Sunnyvale, Calif., for undisclosed terms. J&J, based in New Brunswick, N.J., said it expects to incur a one-time cost of $52 million, or 2 cents per share, related to research and development. Privately held Ensure anticipates beginning clinical trials in 2007 to seek Food and Drug Administration approval for a device used in closing the femoral artery after catheterization. The device is expected to expedite patient recovery, J&J said.
Cordis acquires developer of artery-closing device
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.